Estimating the burden of α-thalassaemia in Thailand using a comprehensive prevalence database for Southeast Asia.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
23 05 2019
Historique:
received: 08 08 2018
accepted: 01 05 2019
entrez: 24 5 2019
pubmed: 24 5 2019
medline: 19 2 2020
Statut: epublish

Résumé

Severe forms of α-thalassaemia, haemoglobin H disease and haemoglobin Bart's hydrops fetalis, are an important public health concern in Southeast Asia. Yet information on the prevalence, genetic diversity and health burden of α-thalassaemia in the region remains limited. We compiled a geodatabase of α-thalassaemia prevalence and genetic diversity surveys and, using geostatistical modelling methods, generated the first continuous maps of α-thalassaemia mutations in Thailand and sub-national estimates of the number of newborns with severe forms in 2020. We also summarised the current evidence-base for α-thalassaemia prevalence and diversity for the region. We estimate that 3595 (95% credible interval 1,717-6,199) newborns will be born with severe α-thalassaemia in Thailand in 2020, which is considerably higher than previous estimates. Accurate, fine-scale epidemiological data are necessary to guide sustainable national and regional health policies for α-thalassaemia management. Our maps and newborn estimates are an important first step towards this aim. This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).

Identifiants

pubmed: 31120421
doi: 10.7554/eLife.40580
pii: 40580
pmc: PMC6533055
doi:
pii:

Substances chimiques

Hemoglobins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Research Council
ID : 268904
Pays : International
Organisme : Medical Research Council
ID : MR/R015600/1
Pays : United Kingdom

Informations de copyright

© 2019, Hockham et al.

Déclaration de conflit d'intérêts

CH, SE, SB, BP, SG, VV, FP No competing interests declared

Références

Lancet Glob Health. 2016 Feb;4(2):e98-e108
pubmed: 26795602
Clin Biochem. 2009 Dec;42(18):1780-5
pubmed: 19733162
Bull World Health Organ. 2008 Jun;86(6):480-7
pubmed: 18568278
J Biomed Biotechnol. 2010;2010:
pubmed: 20871816
Expert Opin Med Diagn. 2010 May;4(3):225-40
pubmed: 23488532
BMC Public Health. 2011 Jan 26;11:53
pubmed: 21266087
Lancet. 2013 Jan 12;381(9861):142-51
pubmed: 23103089
N Engl J Med. 2011 Feb 24;364(8):710-8
pubmed: 21345100
Hematology Am Soc Hematol Educ Program. 2009;:26-34
pubmed: 20008179
Int J Epidemiol. 2012 Jun;41(3):847-60
pubmed: 22617689
Br J Haematol. 2000 Feb;108(2):295-9
pubmed: 10691858
Science. 1908 Jul 10;28(706):49-50
pubmed: 17779291
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5041-5
pubmed: 6946451
Blood. 2004 May 1;103(9):3296-9
pubmed: 14715623
Indian J Med Res. 2011 Oct;134:498-506
pubmed: 22089614
Blood. 2003 Feb 1;101(3):791-800
pubmed: 12393486
Hemoglobin. 1987;11(1):65-88
pubmed: 3294755
N Engl J Med. 2014 Nov 13;371(20):1908-16
pubmed: 25390741
Sci Data. 2017 Jan 31;4:170004
pubmed: 28140397
J Med Assoc Thai. 2009 May;92(5):594-9
pubmed: 19459517
Malar J. 2009 Jul 14;8:155
pubmed: 19602241
JAMA. 2007 May 23;297(20):2220-6
pubmed: 17519411
Indian J Med Res. 2011 Oct;134:493-7
pubmed: 22089613
Cold Spring Harb Perspect Med. 2013 May 01;3(5):a011742
pubmed: 23543077
ScientificWorldJournal. 2009 Jul 13;9:615-25
pubmed: 19618088
Acta Haematol. 2005;114(3):164-6
pubmed: 16227681
Malar J. 2012 Apr 27;11:135
pubmed: 22540175
Ann Hum Biol. 2005 Mar-Apr;32(2):123-30
pubmed: 16096207
Genet Med. 2011 Feb;13(2):83-8
pubmed: 21381239
Malar J. 2013 Nov 15;12:418
pubmed: 24228846
Sci Rep. 2013;3:1671
pubmed: 23591685
Parasit Vectors. 2015 Oct 24;8:560
pubmed: 26496983
Br J Haematol. 2017 Feb;176(3):475-484
pubmed: 27897311
Hematology Am Soc Hematol Educ Program. 2009;:19-25
pubmed: 20008178
PLoS Med. 2012;9(11):e1001339
pubmed: 23152723
Sci Rep. 2017 Jul 5;7(1):4690
pubmed: 28680061
Malays J Pathol. 2017 Apr;39(1):17-23
pubmed: 28413201
Baillieres Clin Haematol. 1998 Mar;11(1):1-51
pubmed: 10872472
Lancet. 1981 Mar 7;1(8219):527-9
pubmed: 6111635
Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):
pubmed: 22908199
J Clin Invest. 1981 Aug;68(2):439-46
pubmed: 6894931
J Clin Invest. 1970 Apr;49(4):635-42
pubmed: 5443168
PLoS Comput Biol. 2010 Apr 01;6(4):e1000724
pubmed: 20369009
Community Genet. 2003;6(1):14-21
pubmed: 12748434
Br J Haematol. 1983 Mar;53(3):411-6
pubmed: 6297530
Genome Res. 2013 Nov;23(11):1852-61
pubmed: 23950147
Hemoglobin. 2016 Jun;40(3):163-7
pubmed: 27117566
Blood. 2017 Mar 9;129(10):1251-1259
pubmed: 28057638

Auteurs

Carinna Hockham (C)

The George Institute for Global Health, Sydney, Australia.
Evolutionary Ecology of Infectious Disease Group, Department of Zoology, University of Oxford, Oxford, United Kingdom.

Supachai Ekwattanakit (S)

Thalassaemia Centre, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Samir Bhatt (S)

Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, United Kingdom.

Bridget S Penman (BS)

Warwick Infectious Disease Epidemiology Research, School of Life Sciences, Warwick University, Coventry, United Kingdom.

Sunetra Gupta (S)

Evolutionary Ecology of Infectious Disease Group, Department of Zoology, University of Oxford, Oxford, United Kingdom.

Vip Viprakasit (V)

Thalassaemia Centre, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Department of Paediatrics, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Frédéric B Piel (FB)

MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH